Bio Gate AG Stock Deutsche Boerse AG
Equities
DE000BGAG981
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
05-01 | Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2024 * | 8.21M 8.83M 12.09M | Sales 2025 * | 10M 10.77M 14.73M | Capitalization | 9.15M 9.84M 13.47M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.11 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.91 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.3% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Lloret-Grau
CEO | Chief Executive Officer | - | 12-01-07 |
Thomas Konradt
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Volker Rofalski
BRD | Director/Board Member | 54 | 11-12-31 |
Karl Richter
CHM | Chairman | - | - |
Volker Alt
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |